EB-12-10101-Z

N/A

Report date: 2024/11/07 16:30:23

Base Information

Drug NameEB-12-10101-Z
Drug Alias NameEB-12-10101-Z
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionVascular endothelial growth factor inhibitors
TargetsVascular endothelial growth factor
Therapy Area/IndicationsEye DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhuhai Essex Bio-Pharmaceutical Co LtdSichuan Kelun-Biotech Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSichuan Kelun-Biotech Biopharmaceutical Co LtdZhuhai Essex Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsEye DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A